Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lascoux

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Clinical Pharmacology|February 13, 1999
Pharmacokinetics and tolerability of intravenous trecovirsen (GEM 91), an antisense phosphorothioate oligonucleotide, in HIV-positive subjectsD Séréni, R Tubiana, C Lascoux, et al.
HIV Medicine|April 6, 2005
Factors associated with virological response in HIV-infected patients failing antiretroviral therapy: a prospective cohort studyS Fournier, C Chaffaut, A Maillard, et al.
The Journal of Infectious Diseases|September 9, 1999
Highly active antiretroviral treatment initiated early in the course of symptomatic primary HIV-1 infection: results of the ANRS 053 trialB Hoen, B Dumon, M Harzic, et al.
Journal of Viral Hepatitis|August 4, 2016
Intensification with pegylated interferon during treatment with tenofovir in HIV-hepatitis B virus co-infected patientsA Boyd, L Piroth, S Maylin, et al.
AIDS (London, England)|August 16, 2001
Early control of HIV replication in primary HIV-1 infection treated with antiretroviral drugs and pegylated IFN alpha: results from the Primoferon A (ANRS 086) StudyD Emilie, M Burgard, C Lascoux-Combe, et al.
HIV Medicine|May 18, 2016
Psychiatric and substance use disorders in HIV/hepatitis C virus (HCV)-coinfected patients: does HCV clearance matter? [Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS) HEPAVIH CO13 cohort]L Michel, C Lions, M Winnock, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Clinical Pharmacology|February 13, 1999
Pharmacokinetics and tolerability of intravenous trecovirsen (GEM 91), an antisense phosphorothioate oligonucleotide, in HIV-positive subjectsD Séréni, R Tubiana, C Lascoux, et al.
HIV Medicine|April 6, 2005
Factors associated with virological response in HIV-infected patients failing antiretroviral therapy: a prospective cohort studyS Fournier, C Chaffaut, A Maillard, et al.
The Journal of Infectious Diseases|September 9, 1999
Highly active antiretroviral treatment initiated early in the course of symptomatic primary HIV-1 infection: results of the ANRS 053 trialB Hoen, B Dumon, M Harzic, et al.
Journal of Viral Hepatitis|August 4, 2016
Intensification with pegylated interferon during treatment with tenofovir in HIV-hepatitis B virus co-infected patientsA Boyd, L Piroth, S Maylin, et al.
AIDS (London, England)|August 16, 2001
Early control of HIV replication in primary HIV-1 infection treated with antiretroviral drugs and pegylated IFN alpha: results from the Primoferon A (ANRS 086) StudyD Emilie, M Burgard, C Lascoux-Combe, et al.
HIV Medicine|May 18, 2016
Psychiatric and substance use disorders in HIV/hepatitis C virus (HCV)-coinfected patients: does HCV clearance matter? [Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS) HEPAVIH CO13 cohort]L Michel, C Lions, M Winnock, et al.
Pageof 2